CELLIBRIUM BIOSCIENCES Trademark
Trademark Overview
On Wednesday, July 30, 2025, a trademark application was filed for CELLIBRIUM BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the CELLIBRIUM BIOSCIENCES trademark a serial number of 99310483. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 13, 2026. This trademark is owned by Cellibrium Biosciences, Inc.. The CELLIBRIUM BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries
Pharmaceutical research and development; research and development services in the field of cell therapy
General Information
| Serial Number | 99310483 |
| Word Mark | CELLIBRIUM BIOSCIENCES |
| Filing Date | Wednesday, July 30, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, January 13, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 13, 2026 |
Trademark Statements
| NOT AVAILABLE | "BIOSCIENCES" |
| Goods and Services | Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries |
| Goods and Services | Pharmaceutical research and development; research and development services in the field of cell therapy |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 30, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Cellibrium Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | East Walpole, MA 02032 |
| Party Name | Cellibrium Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | East Walpole, MA 02032 |
Trademark Events
| Event Date | Event Description |
| Wednesday, July 30, 2025 | NEW APPLICATION ENTERED |
| Wednesday, July 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, December 7, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 15, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, December 17, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, December 17, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 17, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 17, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 17, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 7, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 13, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 13, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
